figuring out the actual risk of COX-2 inhibitors

March 2005

Experts are getting closer to figuring out the actual risk of COX-2 inhibitors...and how to use them appropriately.

The FDA will leave them on the market...with significant warnings.

Vioxx might even come back, now that we know cardiovascular problems aren't unique to Vioxx...and it's the ONLY one so far that has proven GI benefits.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

figuring out the actual risk of COX-2 inhibitors
Sudafed PE, a new version that DOESN'T contain pseudoephedrine
Are all inhalation devices equally effective
Cardiology concerns about Plavix and GI bleeding
Insomnia a new sleeping pill called Lunesta
new concern over Adderall (mixed amphetamines)
guidelines for treating migraines in CHILDREN
Neurology & Pain Palladone, the first long-acting oral hydromorphone
Gastroenterology whether chronic use of stimulant laxatives is harmful
Gastroenterology Is it important for patients to avoid aspirin and NSAIDs before fecal occult blood tests (Hemoccult, etc)
Gastroenterology if drug doses need to be different after gastric bypass surgery
Dermatology benzoyl peroxide often works as well as oral minocycline for mild to moderate facial acne
HIV & AIDS new recommendations for preventing HIV immediately AFTER an exposure
Drug Testing People are asking about drug testing

figuring out the actual risk of COX-2 inhibitors

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents